Key result
Rare IVC leiomyosarcomas typically present at advanced stages and require surgery, chemotherapy, and radiotherapy.
Why the study?
Vascular leiomyosarcomas are rare, often present at an advanced stage, and most departments have minimal experience managing this disease.
This review summarizes current knowledge on the rare presentation, diagnosis, and management of inferior vena cava leiomyosarcoma.
Leiomyosarcomas (LMSs) are malignant neoplasms of soft muscle differentiation that can be classified into five distinct groups according to site-related origin: intra-abdominal, subcutaneous or deep soft tissue of the limbs, cutaneous, external genitalia, and vascular. This distinction reflects different biological behaviors as well as molecular changes, thus reflecting different prognoses and therapeutic options. Vascular LMSs are the least frequent, arising from the walls of the blood vessels, most commonly from the inferior vena cava. Due to its deep location, symptoms are non-specific, and the disease presents at an advanced stage, sometimes with metastases. Surgery is the treatment of choice, associated with chemo- and radiotherapy. Due to its rarity, most departments have minimal experience handling this disease. This article reviews the current knowledge on vascular leiomyosarcomas, particularly the inferior vena cava leiomyosarcoma.
No takes yet. Share an insight, caveat, or question.
Gama et al. (2024) conducted a review in Inferior vena cava leiomyosarcoma. Vascular leiomyosarcomas of the inferior vena cava are rare, deep-seated tumors that typically present at an advanced stage and are primarily managed with surgery, chemotherapy, and radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: